
Jefferies raised its price target on Alphabet (GOOGL) to $285 with a Buy rating, citing confidence in the company's AI leadership, particularly Gemini's potential to transform search into an "ultimate decision engine" through integrated AI and multi-modal features. This positive sentiment is reinforced by Mizuho's Outperform initiation, highlighting AI-driven growth in advertising and cloud, alongside Google's recent integration of Gemini into Chrome and expanded AI Search capabilities. Concurrently, Google is preparing to propose changes to its ad tech business following an EU fine, without a full Ad Manager divestiture.
Alphabet (GOOGL) is receiving strong bullish support from Wall Street, primarily driven by confidence in its artificial intelligence strategy. Jefferies raised its price target to $285, justifying the increase with a 15x EV/EBITDA multiple, a significant premium to the company's 10-year average of 12.5x, reflecting heightened growth expectations. This optimism, echoed by Mizuho's initiation with an Outperform rating, centers on Gemini's potential to evolve Google Search into an "ultimate decision engine" by unifying AI-driven chat, traditional search, and multi-modal features like Circle to Search. This strategy aims to control the high-value funnel from user discovery to purchase. The thesis is supported by tangible product developments, including the integration of Gemini into the Chrome browser and the expansion of AI Mode in Search. While the stock has shown significant momentum, returning 54.89% over the past six months alongside steady 13.13% revenue growth, investors must also weigh two key headwinds: internal restructuring, evidenced by recent layoffs in the Google Cloud division, and persistent regulatory pressure, demonstrated by the impending changes to its ad tech business in response to a €3 billion EU fine.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.75
Ticker Sentiment